Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d007df0e92f4a5cb4c6420e2c4309c1 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-256 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2015-0065 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2015-1081 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56966 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N15-1031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0686 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0602 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-23 |
filingDate |
2008-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18bbaade9cab38183c43f61c5ef70d99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f6c0b908ef25d9a801dde2fb78a7954 |
publicationDate |
2014-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20140147150-A |
titleOfInvention |
Selective cell therapy for the treatment of renal failure |
abstract |
An isolated population of kidney cells harvested from differentiated cells of the kidney, which is expanded in vitro, is provided herein. The kidney cells may comprise kidney periurethral stromal cells, and preferably are capable of producing erythropoietin (EPO). Kidney cells can also be selected based on EPO production. A method of producing an isolated population of EPO producing cells is also provided and comprises administering the population to a patient whereby the cells produce EPO in vivo, Methods of treating renal disease resulting in EPO production are provided. |
priorityDate |
2007-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |